• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Biogen Idec Inc

+ Add to Watchlist

IDP:GR

214.100 EUR 4.801 2.19%

As of 10:30:55 ET on 04/24/2014.

Snapshot for Biogen Idec Inc (IDP)

Open: 224.020 Day's Range: 210.450 - 226.000 Volume: 313
Previous Close: 218.901 52wk Range: 148.087 - 258.500 1-Yr Rtn: +34.40%

Stock Chart for IDP

No chart data available.
  • IDP:GR 214.150
  • 1D
  • 1M
  • 1Y
218.901
Interactive IDP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IDP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 25.7931
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 11.4740
Est. PEG Ratio 1.2891
Market Cap (M EUR) 50,784.48
Shares Outstanding (M) 237.20
30 Day Average Volume 1,317
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/25/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IDP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IDP

Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.

George A ScangosChief Executive OfficerSusan H AlexanderExec VP/Chief Legal Ofcr/Secy
Paul J ClancyExec VP:Finance/CFOStephen H Holtzman "Steve"Exec VP:Corporate Development
More Company Profile & Key Executives for IDP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil